左甲状腺素治疗甲减时全身甲状腺激素状态:系统综述与荟萃分析
该系统综述与荟萃分析检索并汇总了99项研究,评估左甲状腺素单药治疗使血清TSH正常化的原发性甲减成人中其他甲状腺激素信号客观标志物的状态。荟萃分析显示,与对照相比,TSH正常化者血清LDL高3.31±1.64 mg/dL(p=0.044)、总胆固醇高9.60±3.55 mg/dL(p=0.007),提示并非所有系统性生物学标志物均被正常化。
要点
- TSH正常化后LDL与总胆固醇仍高于对照,提示左甲状腺素单药未必完全恢复甲状腺激素信号。
- SHBG在左甲状腺素治疗者与对照间无显著差异(基于2项研究的荟萃分析)。
- 评估甲减治疗充分性时,除TSH外可关注LDL、总胆固醇等客观标志物。
核心结论
- 在左甲状腺素单药使血清TSH正常化的原发性甲减研究中,并非所有系统性甲状腺激素信号生物学标志物均被正常化,包括血清LDL与总胆固醇。
研究设计与样本
- 系统综述与荟萃分析,检索报告甲状腺激素信号客观标志物的研究,纳入99项符合标准的研究,其中65项报告血清胆固醇数据。
- 纳入对象为非妊娠成人原发性甲减、左甲状腺素单药治疗且血清TSH正常者。
- 对LDL、总胆固醇和SHBG结局采用随机效应荟萃分析合并数据。
主要发现
- 荟萃分析显示,TSH正常的左甲状腺素治疗者较对照血清LDL高3.31±1.64 mg/dL(p=0.044)。
- 同组血清总胆固醇较对照高9.60±3.55 mg/dL(p=0.007)。
- 在未同时评估健康对照的研究中,血清LDL为138.3±4.6 mg/dL(p<0.001),总胆固醇为209.6±3.4 mg/dL(p<0.001)。
- 2项研究的荟萃分析显示左甲状腺素治疗者与对照的SHBG水平无显著差异。
临床怎么用
- 对左甲状腺素单药治疗且TSH正常的原发性甲减患者,可关注LDL与总胆固醇等标志物以评估甲状腺激素信号的全身恢复情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The standard of care for overt hypothyroidism is levothyroxine at doses that normalize serum TSH levels. Whether this approach universally restores thyroid hormone signaling is unknown. OBJECTIVE: To review studies of overt hypothyroidism in which participants were treated with levothyroxine to normalize serum TSH levels and measured other objective markers of thyroid hormone signaling. DESIGN: Databases were searched for studies that reported objective markers of thyroid hormone signaling (serum low-density lipoprotein (LDL), total cholesterol (TC), sex hormone-binding globulin (SHBG), creatine kinase and/or ferritin levels; cognition, energy expenditure, and/or renal function) in levothyroxine monotherapy for overt, primary hypothyroidism among nonpregnant adults with normal serum TSH levels. For studies with LDL, TC and SHBG outcomes, data were pooled using random effects meta-analysis. RESULTS: A total of 99 studies met inclusion criteria, including 65 that reported serum cholesterol data. Meta-analysis showed that levothyroxine-treated hypothyroid participants with normal serum TSH levels had 3.31 ± 1.64 mg/dL higher serum LDL levels (p=0.044) and 9.60 ± 3.55 mg/dL higher serum TC levels (p=0.007) compared to controls. In studies that did not concomitantly assess healthy controls, serum LDL levels were 138.3 ± 4.6 mg/dL (p<0.001) and serum TC levels were 209.6 ± 3.4 mg/dL (p<0.001). Meta-analysis of 2 studies showed no significant difference between SHBG levels of levothyroxine-treated participants and controls. CONCLUSIONS: In studies that utilized levothyroxine monotherapy at doses that normalized the serum TSH for overt, primary hypothyroidism, not all systemic biological markers of thyroid hormone signaling were normalized, including serum LDL and TC levels.
引用
- McAninch EA, Rajan KB, Miller CH, et al. Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2018. PMID: 30124904. doi:10.1210/jc.2018-01361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。